News & Publications Press Releases Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress Publications 2024 European Respiratory Society Congress ATMOS Poster2025 American Thoracic Society Congress ATMOS Poster2025 American Thoracic Society Congress Real World Evidence Poster